PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes

Conditions: Myelodysplastic Syndromes Interventions: Drug: IV Decitabine; Drug: Decitabine and cedazuridine; Drug: only Decitabine and cedazuridine Sponsors: Otsuka Beijing Research Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials